Untreated cervical cancer can spread to the bladder, intestines, lymph nodes, bones, lungs, and liver.
According to the American Cancer Center, an estimated 13,000 plus new cases of invasive cervical cancer will be diagnosed in the U.S. in 2019. Although one of the most treatable types of cancer when diagnosed before it becomes invasive, according to the American Cancer Society, more than 4,000 women tragically will tragically die in the United States this year from invasive cervical cancer.
To focus attention on cervical cancer and the Human Papillomavirus (HPV), the overwhelming leading cause of cervical cancer, the U.S. Congress has designated January as Cervical Cancer Awareness Month.
Because during its initial stages, cervical cancer does not cause any symptoms, regular screening to detect abnormal cervical cancer cells at their earliest development is essential to the prompt diagnosis and effective treatment of cervical cancer. Cervical cancer misdiagnosis happens when there are clear signs that a doctor should have caught, yet the cancer goes untreated, leading to health complications.
Contact our Cervical Cancer Misdiagnosis Attorneys at Frischman & Rizza for a free case evaluation.
(412) 291-9377
The Papanicolaou test (Pap smear), which first gained recognition in the 1940s as an effective screening test for cervical cancer, is now widely acclaimed and routinely performed as part of a woman’s regular gynecologic care. There is no doubt that the widespread use of Pap smear testing has led to a significant decrease in cervical cancer deaths over the past 40 years.
During a Pap smear, which is performed in a physician’s office, the physician will use a swab to obtain cells from the cervix. The specimen is then forwarded to the lab for evaluation by cytotechnologists and, in certain situations, pathologists.
Pap smears identify pre-cancerous and cancerous cells on the cervix. The American College of Obstetricians and Gynecologists recommend women ages 21-30 be screened for cervical cancer every 2 years. Once a woman reaches age 30 until she is age 65, it is recommended that she undergo screening by means of a Pap smear every 3 years so long as prior exams do not reveal any abnormalities. After age 65, additional Pap smear screening is not recommended for women who have had prior adequate screening and are not at high risk for developing cervical cancer.
In the event of an abnormal Pap smear, follow-up examination and/or treatment is required. Depending upon the nature of the abnormality, the follow-up examination and/or treatment can include a follow-up Pap smear, a colposcopy (a scope that is used to visually examine the cervix), loop electrosurgical excision procedure (LEEP), biopsy, endocervical scraping and/or a cone biopsy. The failure or delay in performing follow-up examination and/or treatment for an abnormal Pap smear can lead to a worsening prognosis.
Some of the most common causes of medical malpractice claims involving the failure and/or delay in the diagnosis and treatment of cervical cancer include:
The 5-year survival rate identifies the percentage of women who are alive 5 years after their cervical cancer is first diagnosed. Survival rates depend upon many factors including the stage of the cervical cancer at the time it was diagnosed and its aggressiveness based upon its microscopic cellular characteristics.
Based upon the American Joint Committee on Cancer’s 2017 Staging Manual, the 5-year survival rate for women diagnosed with cervical cancer is as follows:
Although awareness as to the importance of Pap smear testing has fortunately resulted in a steep decline in deaths from cervical cancer, there are still too many women who die unnecessarily from this disease.
7300 Penn Ave, Pittsburgh, PA 15208
Phone: (412) 291-9377
201 Basin St Unit #8, Williamsport, PA 17701
Phone: (570) 605-4126
